Pilot Introduction of Oral Cholera Vaccine in Orissa, India
NCT01365442 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 31552
Last updated 2013-05-23
Summary
The purpose of this study is to provide evidence for policymakers and key opinion leaders on the pilot implementation of cholera vaccination using the newly licensed Oral Cholera Vaccine (OCV) in India. The pilot introduction will provide the evidence for the feasibility, costs and population acceptance of large-scale cholera vaccination using the Indian vaccine (using vaccination coverage rates and other measures).
Conditions
- Cholera
Sponsors & Collaborators
-
Department of Health and Family Welfare, Orissa
collaborator OTHER -
Indian Council of Medical Research
collaborator OTHER_GOV -
National Institute of Cholera and Enteric Diseases, India
collaborator OTHER -
Shantha Biotechnics Limited
collaborator INDUSTRY -
International Vaccine Institute
lead OTHER
Principal Investigators
-
Shantanu K Kar, MD · Director, Regional Medical Research Center, Bhubaneswar, Orissa, India
Eligibility
- Min Age
- 12 Months
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-05-31
- Primary Completion
- 2012-03-31
- Completion
- 2012-09-30
Countries
- India
More Related Trials
-
Safety and Immunogenicity of Locally Manufactured New (HL-OCV) Oral Cholera Vaccine
NCT02823899 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Immunogenicity of Locally Manufactured Oral Cholera Vaccine
NCT02742558 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Safety and Immunogenicity of the Bivalent Killed Whole Cell Oral Cholera Vaccine in Adults and Children
NCT00760825 ·Status: COMPLETED ·Phase: PHASE4
-
Immune Non-Inferiority, Safety and Lot-to-Lot Consistency of Oral Cholera Vaccine-Simplified Compared to Shanchol™
NCT04760236 ·Status: COMPLETED ·Phase: PHASE3
-
A Post-marketing Observational Study of Oral Cholera Vaccine
NCT07300462 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Immunogenicity of Co-administered Oral Polio Vaccine and Oral Cholera Vaccine
NCT03581734 ·Status: UNKNOWN ·Phase: PHASE3
-
VAXCHORA Pediatric Study to Assess Safety and Immunogenicity
NCT03220737 ·Status: COMPLETED ·Phase: PHASE4
-
To Evaluate Safety of Oral Cholera Vaccine Hillchol® (BBV131)
NCT05732766 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study to Evaluate the Safety of Tetravalent Rotavirus Vaccine in Healthy Indian Adult Male Volunteers
NCT01091298 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase III Clinical Trial to Evaluate the Protective Efficacy of Three Doses of Oral Rotavirus Vaccine (ORV) 116E
NCT01305109 ·Status: UNKNOWN ·Phase: PHASE3
-
Immunologic Responses to a Live Attenuated Oral Cholera Vaccine
NCT03251495 ·Status: COMPLETED ·Phase: PHASE2
-
Immunogenicity of Cholera Vaccine in Children With IBD
NCT03998449 ·Status: COMPLETED ·Phase: NA
-
A Phase III Randomized, Modified Double-blind, Multi-centric, Comparative Study, to Evaluate the Non-inferiority of Immunogenicity and Safety of Hillchol® (BBV131)to Shanchol™ Along With Lot-to-lot Consistency of Hillchol®(BBV131).
NCT05507229 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in the Philippines
NCT01949675 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Immunogenicity Study of the Tetravalent Rotavirus Vaccine
NCT01061658 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Phase 1b Ascending Dose Study of PanChol in Healthy Volunteers
NCT07107516 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in Dominican Republic
NCT02434822 ·Status: COMPLETED ·Phase: PHASE3
-
Follow-up of Pregnant Women After a Mass Vaccination of Oral Cholera Vaccine (ShancholTM) in Nsanje Malawi
NCT02499172 ·Status: TERMINATED ·Phase: NA
-
Poliovirus Vaccine Trial in Bangladesh
NCT01633216 ·Status: COMPLETED ·Phase: PHASE4
-
Exploration of the Biologic Basis for Underperformance of Oral Polio and Rotavirus Vaccines in INDIA (PROVIDE)
NCT01571505 ·Status: COMPLETED ·Phase: PHASE1
-
Concomitant Use and Staggered Use of Vaccine and Oral Poliovirus (OPV) in Healthy Infants (V260-014)(COMPLETED)
NCT00130832 ·Status: COMPLETED ·Phase: PHASE3
-
Development of a Live Attenuated Rotavirus Vaccine as a Human Infection Challenge Model
NCT04123119 ·Status: COMPLETED ·Phase: NA
-
Phase I Clinical Trial of Inactivated Rotavirus Vaccine in a Population Aged 6 Weeks-49 Years Old
NCT06350058 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Long-term Immunogenicity and Safety of Fourth Administration of Boryung Cell-Culture Japanese Encephalitis Vaccineinj
NCT02532569 ·Status: COMPLETED ·Phase: PHASE4
-
Diarrhea and Bivalent Oral Polio Vaccine Immunity
NCT01559636 ·Status: COMPLETED ·Phase: NA